Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Lovastatin - Generic Drug Details

« Back to Dashboard

What are the generic sources for lovastatin and what is the scope of lovastatin patent protection?

is the generic ingredient in three branded drugs marketed by Sandoz, Covis Pharma Bv, Sun Pharm Inds, Actavis Elizabeth, Mylan, Merck, Apotex Inc, Teva, Carlsbad, and Lupin, and is included in twelve NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lovastatin has thirty-three patent family members in twelve countries.

There are thirty-three drug master file entries for lovastatin. Forty-one suppliers are listed for this compound.

Summary for Generic Name: lovastatin

Drug Master File Entries: see list33
Suppliers / Packagers: see list41
Bulk Api Vendors: see list66
Clinical Trials: see list17
Patent Applications: see list6,339
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lovastatin at DailyMed

Pharmacology for Ingredient: lovastatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv
TABLET, EXTENDED RELEASE;ORAL021316-003Jun 26, 2002RXYesNo5,916,595► Subscribe ► Subscribe
TABLET;ORAL075451-002Dec 17, 2001ABRXNoNo► Subscribe► Subscribe
TABLET;ORAL075300-003Dec 17, 2001ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
TABLET;ORAL075828-001Dec 17, 2001ABRXNoNo► Subscribe► Subscribe
Covis Pharma Bv
TABLET, EXTENDED RELEASE;ORAL021316-004Jun 26, 2002RXYesYes6,485,748► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus